Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microdose intravenous pharmacokinetic study of [14C]-GSK2239633 in healthy male subjects
NL-OMON35064Active, not recruiting
- Sponsor
- GSK
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of GSK2239633 in asthma, sponsored by GSK. Primary endpoints: Intravenous pharmacokinetics of GSK2239633, Plasma total radioactivity relative to parent drug and 1 more. Started Feb 2010; status: active, not recruiting.
02
Drugs
GSK2239633
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON35064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35064.